VEGF polymorphisms are not associated with an increased risk of developing renal cell carcinoma in Spanish population

Human Immunology

Volumn 74, Issue 1, 2013, Pages 98-103

  Sáenz López, Pablo ^a,b   Vazquez, Fernando ^b   Cozar, Jose Manuel ^b   Carretero, Rafael ^a,b   Garrido, Federico ^a,b   Ruiz Cabello, Francisco ^a,b  

^a UNIVERSITY OF GRANADA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; ETHNIC GROUP; FEMALE; GENOTYPING TECHNIQUE; HAPLOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; SAMPLE SIZE; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN; TUMOR VOLUME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM GRADING; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RISK; SPAIN; SURVIVAL ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84870907629     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.10.014     Document Type: Article

References (29)

1. Galligioni E., Ferro A. Angiogenesis and antiangiogenic agents in non-small cell lung cancer. Lung Cancer 2001, 34:3.
2. Carmeliet P., Jain R.K. Angiogenesis in cancer and other diseases. Nature 2000, 407:249.
3. Ferrara N., Gerber H.P., LeCouter J. The biology of VEGF and its receptors. Nat Med 2003, 9:669.
4. Neufeld G., Cohen T., Gengrinovitch S., et al. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 1999, 13:9.
5. Vincenti V., Cassano C., Rocchi M., et al. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation 1996, 93:1493.
6. Berse B., Brown L.F., Van De Water L., et al. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol Biol Cell 1992, 3:211.
7. Jakubowska A., Gronwald J., Menklszak J., et al. The VEGF_936_C>T 3' UTR polymorphism reduces BRCA1-associated breast cancer risk in Polish women. Cancer Lett 2008, 262:71.
8. Brogan I.J., Khan N., Isaac K., et al. Novel polymorphisms in the promoter and 5' UTR regions of the human vascular endothelial growth factor gene. Hum Immunol 1999, 60:1245.
9. Renner W., Kotschan S., Hoffmann C., et al. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res 2000, 37:443.
10. Watson C.J., Webb N.J., Bottomley M.J., et al. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine 2000, 12:1232.
11. Dassoulas K., Gazouli M., Rizos S., et al. Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival. Mol Carcinog 2009, 48:563.
12. Jin Q., Hemminki K., Enquist K., et al. Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis. Clin Cancer Res 2005, 11:3647.
13. Langsenlehner T., Langsenlehner U., Renner W., et al. Single nucleotide polymorphisms and haplotypes in the gene for vascular endothelial growth factor and risk of prostate cancer. Eur J Cancer 2008, 44:1572.
14. Na X., Wu G., Ryan C.K., et al. Overproduction of vascular endothelial growth factor related to von Hippel-Lindau tumor suppressor gene mutations and hypoxia-inducible factor-1 alpha expression in renal cell carcinomas. J Urol 2003, 170:588.
15. Albiges L., Salem M., Rini B., et al. Vascular endothelial growth factor-targeted therapies in advanced renal cell carcinoma. Hematol Oncol Clin North Am 2011, 25:813.
16. Kawai Y., Sakano S., Korenaga Y., et al. Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas. Eur Urol 2007, 52:1147.
17. Abe A., Sato K., Habuchi T., et al. Single nucleotide polymorphisms in the 3' untranslated region of vascular endothelial growth factor gene in Japanese population with or without renal cell carcinoma. Tohoku J Exp Med 2002, 198:181.
18. Bruyère F., Hovens C.M., Marson M.N., et al. VEGF polymorphisms are associated with an increasing risk of developing renal cell carcinoma. J Urol 2010, 184:1273.
19. Lam J.S., Shvarts O., Leppert J.T., Pantuck A.J., Figlin R.A., Belldegrun A.S. Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system. J Urol 2005, 174:466-472.
20. Lee J.S., Kim H.S., Jung J.J., et al. Expression of vascular endothelial growth factor in renal cell carcinoma and the relation to angiogenesis and p53 protein expression. J Surg Oncol 2001, 77:55.
21. Jacobsen J., Rasmuson T., Grankvist K., et al. Vascular endothelial growth factor as prognostic factor in renal cell carcinoma. J Urol 2000, 163:343.
22. Paradis V., Lagha N.B., Zeimoura L., et al. Expression of vascular endothelial growth factor in renal cell carcinomas. Virchows Arch 2000, 436:351.
23. Ding C., Cantor C.R. Direct molecular haplotyping of long-range genomic DNA with M1-PCR. Proc Natl Acad Sci USA 2003, 100:7449.
24. García-Closas M., Malats N., Real F.X., et al. Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk. PLoS Genet 2007, 3:29.
25. Rodríguez-Rodríguez L., García-Bermúdez M., González-Juanatey C., et al. Vascular endothelial growth factor A and cardiovascular disease in rheumatoid arthritis patients. Tissue Antigens 2011, 77:291.
26. Zhao Z.Z., Nyholt D.R., Thomas S., et al. Polymorphisms in the vascular endothelial growth factor gene and the risk of familial endometriosis. Mol Hum Reprod 2008, 14:531.
27. Heist R.S., Zhai R., Liu G., et al. VEGF polymorphisms and survival in early-stage non-small-cell lung cancer. J Clin Oncol 2008, 26:856.
28. Wang K., Liu L., Zhu Z.M., et al. Five polymorphisms of vascular endothelial growth factor (VEGF) and risk of breast cancer: a meta-analysis involving 16,703 individuals. Cytokine 2011, 56:167.
29. Zhou Y., Li N., Zhuang W., Wu X. Vascular endothelial growth factor (VEGF) gene polymorphisms and gastric cancer risk in a Chinese Han population. Mol Carcinog 2011, 50:184.